CLOV insider trades & Congress trades
Clover Health Investments, Corp. /de: public insider filings and Congress disclosures, in one place.
Bourse has recorded 18 open-market insider transactions in Clover Health Investments, Corp. /de (CLOV) (0 purchases with code P and 18 sales with code S), the most recent on October 20, 2026.
In the last 90 days: 0 purchases by 0 insiders ($0) and 18 sales by 6 ($4.17M).
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Oct 20, 2026 | Soares Karen | Chief Legal Officer | Sell | 19,275 | $4.66 | $90K | – |
| Oct 19, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 4,066 | $4.41 | $18K | – |
| Oct 15, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 18,273 | $4.68 | $86K | – |
| Oct 15, 2026 | Wai Conrad | CEO, Counterpart Health | Sell | 23,627 | $4.68 | $111K | – |
| Oct 15, 2026 | Thornton Joseph Clay | Interim CFO | Sell | 4,591 | $4.68 | $21K | – |
| Oct 15, 2026 | Soares Karen | Chief Legal Officer | Sell | 14,673 | $4.68 | $69K | – |
| Oct 15, 2026 | Toy Andrew | Chief Executive Officer | Sell | 62,176 | $4.68 | $291K | – |
| Oct 7, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 2,006 | $4.63 | $9K | – |
| Oct 5, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 8,750 | $4.42 | $39K | – |
| Oct 1, 2026 | Toy Andrew | Chief Executive Officer | Sell | 318,806 | $4.19 | $1.34M | +0.0% |
| Sep 17, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 1,921 | $4.56 | $9K | −0.0% |
| Sep 16, 2026 | Oldakowski Joseph Frank | VP OF FINANCE AND CONTROLLER | Sell | 3,170 | $4.64 | $15K | +0.0% |
| Sep 15, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 9,273 | $4.78 | $44K | +0.0% |
| Sep 15, 2026 | Soares Karen | Chief Legal Officer | Sell | 6,846 | $4.78 | $33K | +0.0% |
| Sep 15, 2026 | Wai Conrad | CEO, Counterpart Health | Sell | 300,000 | $4.72 | $1.42M | +0.0% |
| Sep 14, 2026 | Oldakowski Joseph Frank | VP OF FINANCE AND CONTROLLER | Sell | 20,000 | $5.16 | $103K | – |
| Aug 17, 2026 | Thornton Joseph Clay | Interim CFO | Sell | 17,775 | $4.39 | $78K | +0.1% |
| Aug 10, 2026 | Toy Andrew | Chief Executive Officer | Sell | 87,798 | $4.65 | $408K | −0.1% |
Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.